Patrycja Alicja Rozwadowska-Kunecka

Ms. Patrycja Alicja Rozwadowska-Kunecka

Pediatric Neurology, Medical University of Silesia, Katowice, Śląskie, Poland
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
PBPiotr Bator
Piotr Bator
MRMichał Razik
Michał Razik
PRPatrycja Alicja Rozwadowska-Kunecka
Patrycja Alicja Rozwadowska-Kunecka
JRJan Ramian
Jan Ramian
JRJakub Rybak
Jakub Rybak
WRWiktor Razik
Wiktor Razik
Introduction and purpose: Apples are a widely consumed fruit globally and are known to be a great source of nutrition. Studies have shown that apples contain high levels of antioxidants, dietary fiber, and vitamins that contribute to numerous health benefits. This paper aims to provide a comprehensive review of the impact of apples on human health. State of knowledge: The paper reviews the current literature on the health benefits of apples, focusing on their impact on various health conditions such as cancer, cardiovascular diseases, diabetes, and obesity. Additionally, it examines the role of apples in improving intestinal, immune, and cognitive function. The paper also discusses the potential mechanisms by which apples exert their health benefits, such as high levels of flavonoids, polyphenols, and dietary fiber. Summary: In conclusion, the vast body of evidence reviewed in this paper supports the notion that consuming apples regularly can contribute to better health outcomes. They may help reduce the risk of chronic diseases, such as cancer, cardiovascular diseases, and diabetes, as well as promote healthy gut microbiota and immune function. Despite the controversy surrounding the use of pesticides in apple cultivation, the benefits of consuming apples outweigh the risks. Therefore, it is highly recommended to include apples as part of a balanced and nutritious diet to promote optimal health and wellbeing. As the saying goes, "An apple a day keeps the doctor away".

16 February 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
PRPatrycja Alicja Rozwadowska-Kunecka
Patrycja Alicja Rozwadowska-Kunecka
PBPiotr Bator
Piotr Bator
MRMichał Razik
Michał Razik
JRJan Ramian
Jan Ramian
JRJakub Rybak
Jakub Rybak
WRWiktor Razik
Wiktor Razik
Introduction and purpose: Berberine is a plant alkaloid that naturally occurs in the fruits of common barberry (Berberis vulgaris). This alkaloid has long been used in natural medicine. It exhibits a range of bioactivities, such as antioxidant, anti-inflammatory, antidiabetic, anti-edema, and antimicrobial actions. Through the promising therapeutic effects of berberine in metabolic syndrome, as well as its impact on carcinogenesis, this compound is beginning to play a significant role in preventive medicine. Recently, particular attention has been paid to the anticancer properties of berberine, which are based on many biochemical pathways, particularly its pro-apoptotic and anti-inflammatory action. The study aimed to review the anticancer mechanisms of berberine and summarize them about individual cancers. State of knowledge: The article reviews the current literature on the anticancer properties of berberine for individual cancers, focusing primarily on its molecular mechanisms of action. In addition, the potential of berberine as a promising candidate forming the basis for drug production and its use in preventive medicine was analyzed. Summary:  In summary, many studies have shown that berberine exhibits anticancer activity in many types of cancers, including breast, lung, stomach, liver, colorectal, ovarian, cervical, and prostate cancers. Berberine inhibits the growth of cancer cells, limits metastases, induces apoptosis, stimulates autophagy, and enhances the effectiveness of anticancer drugs. Despite its potential as a promising candidate for drug production, there are currently no approved pure berberine preparations for the treatment of specific ailments. Research on its effectiveness and safety is still ongoing.

24 November 2022 in Children
Verified
Journal Article
Open access
PDF file
MRMałgorzata Maria Rodak
Małgorzata Maria Rodak
MJMariola Jonderko
Mariola Jonderko
PRPatrycja Alicja Rozwadowska-Kunecka
Patrycja Alicja Rozwadowska-Kunecka
MMMagdalena Dagmara Machnikowska-Sokołowska
Magdalena Dagmara Machnikowska-Sokołowska
Justyna PaprockaJustyna Paprocka
Justyna Paprocka
CDKL5 deficiency disorder (CDD) is a developmental encephalopathy caused by pathogenic variants in the X-linked cyclin-dependent kinase 5 (CDKL5) gene. This rare disorder occurs more frequently in females than in males. The incidence is estimated to be approximately 1: 40,000–60,000 live births. So far, 50 cases have been described in boys. The clinical course in males tends to be more severe and is often associated with death in the first or second decade of life. The authors present an unreported 2.5-year-old male patient with drug-resistant epilepsy who was diagnosed with a de novo mutation in the CDKL5 gene. First seizures developed in the fifth week of life and have progressed steadily since then. The child’s psychomotor development was strongly delayed, and generalized hypotonia was noticed since birth. Brain MRI showed areas of incomplete myelination, posterior narrowing of the corpus callosum, a pineal cyst of up to 3 mm, and open islet lids. Intensive antiseizure medications (ASMs), a ketogenic diet, and steroid therapy were not successful. Short-term improvement was achieved with the implantation of a vagal nerve stimulator (VNS). Due to the progressive course of the disease, the boy requires frequent modification of ASMs.

Verified
Journal Article
Open access
PDF file
Karolina Bajdak-RusinekKarolina Bajdak-Rusinek
Karolina Bajdak-Rusinek
NDNatalia Diak
Natalia Diak
ATAnna Trybus
Anna Trybus
Agnieszka Fus-KujawaAgnieszka Fus-Kujawa
Agnieszka Fus-Kujawa
MSMarcelina Salamon
Marcelina Salamon
PRPatrycja Alicja Rozwadowska-Kunecka
Patrycja Alicja Rozwadowska-Kunecka
Epithelial–mesenchymal plasticity encompasses a spectrum of epithelial and mesenchymal identity states that enable cells to adapt to changing biological contexts. While CD44 isoform usage and epithelial splicing regulators ESRP1/2 are well-characterized in cancer-associated epithelial–mesenchymal transition (EMT), their regulation across physiological, non-transformed identity states remains less well defined. Here, we employed a non-malignant human cellular system comprising primary dermal fibroblasts, induced pluripotent stem (iPS) cells, and iPS-derived mesenchymal stem cells (iPS-MSCs) to define discrete epithelial, intermediate epithelial/mesenchymal, and mesenchymal identity states positioned along an epithelial–mesenchymal identity axis. Morphological assessment, lineage marker profiling, and RT-qPCR analyses revealed reproducible population-level stratification of these states. CD44 expression and alternative splicing followed this hierarchy, with CD44s predominating in fibroblasts, broad variant exon inclusion in iPS cells, and intermediate patterns in iPS-MSCs. ESRP1 expression mirrored CD44 splicing architecture, and ESRP1 silencing in iPS cells induced a shift toward CD44s, confirming its functional contribution to epithelial-associated CD44 splicing. In contrast, Notch-related transcriptional readouts displayed distinct, context-dependent profiles across the examined identity states. Together, this study establishes a tractable non-transformed human model that captures selected molecular features associated with epithelial–mesenchymal plasticity beyond malignant contexts.

27 June 2023 in Medicina
Verified
Journal Article
Open access
PDF file
MRMichał Razik
Michał Razik
PRPatrycja Alicja Rozwadowska-Kunecka
Patrycja Alicja Rozwadowska-Kunecka
AKAnna Koclęga
Anna Koclęga
GHGrzegorz Helbig
Grzegorz Helbig
The occurrence of secondary neoplasms in adult patients treated with chemotherapy in childhood is not uncommon. Prior chemotherapy is found to be an independent risk factor for the development of secondary malignancies, which are usually associated with a worse prognosis. The presented case is a 35-year-old female patient who was diagnosed with Ewing sarcoma in her late adolescence. The tumor was successfully treated with chemotherapy, but 3 years later she was diagnosed with T-cell lymphoblastic lymphoma. The patient received allogeneic hematopoietic stem cell transplantation (allo-HSCT) from human leukocyte antigen (HLA) matched related donor. The procedure was complicated by grade 2 acute graft-versus-host disease (GvHD) which resolved after implementation of immunosuppressive treatment. However, a year later, the patient developed extensive chronic GvHD (cGvHD) and required reintroduction of immunosuppressants. Prolonged immunosuppressive treatment with tacrolimus led to irreversible kidney failure. After a 2-year period of regular peritoneal dialysis, she was found to be eligible for a kidney transplant from a deceased donor. Now, 15 years after stem cell transplantation and 8 years after kidney transplantation, the patient remains in good condition overall, presenting with symptoms of limited cGvHD. The case described here presents a unique clinical scenario of a female patient who was successfully treated for her double malignancy. Moreover, she underwent effective double transplantations and was eventually found to be cured despite accompanying complications.

16 February 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
BMBarbara Magiera
Barbara Magiera
JRJakub Rybak
Jakub Rybak
KMKarol Magiera
Karol Magiera
PBPiotr Bator
Piotr Bator
MRMichał Razik
Michał Razik
WRWiktor Razik
Wiktor Razik
Introduction and purpose: Obesity is one of the most serious health challenges in modern society. Over the last 40 years, the number of obese school-age children has increased tenfold. This not only has significant consequences for physical health, but also affects psychosocial aspects and the quality of life of the young generation. The aim of this study is to conduct a comprehensive review of the literature on obesity among children and adolescents, focused on identifying the main risk factors and analyzing effective forms of prevention. Materials and methods: A review of the literature available in the "PubMed" database and books was conducted. The search was performed by using the following keywords: "childhood obesity", "childhood obesity risk factors", “childhood obesity prevention” State of knowledge: The risk factors for obesity in children and adolescents include genetic factors, endocrine diseases, improper diet, low physical activity, low socioeconomic status, stress, psychological factors, short sleep time, medications, hypothalamic obesity and H. pylori. As part of the prevention of obesity in children and adolescents, it is recommended to develop appropriate habits in children and adolescents. The influence of parents on health behaviors in children is important. Top-down activities such as health campaigns and legal regulations also have a significant impact. Summary: Due to research conducted over the years, awareness of obesity risk factors has increased. To effectively prevent this disease, an integrated approach is necessary, taking into account both education and changes in the social environment. Implementing these strategies requires cooperation at local, regional, national and international levels.